BCM
PFE icon

Bluefin Capital Management’s Pfizer PFE Stock Holding History

Bluefin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-270,100
Closed -$5.15K – 260
2023
Q4 		$5.15K Buy
+270,100
New +$8.17M ﹤0.01% 195
2023
Q1 		– Sell
-101,600
Closed -$1.96K – 403
2022
Q4 		$1.96K Hold
101,600
– – ﹤0.01% 416
2022
Q3 		$9K Sell
101,600
-12,000
-11% -$583K ﹤0.01% 468
2022
Q2 		$130K Sell
113,600
-73,300
-39% -$3.74M 0.01% 339
2022
Q1 		$267K Sell
186,900
-355,200
-66% -$18.4M 0.02% 289
2021
Q4 		$4.47M Buy
542,100
+408,500
+306% +$20.2M 0.31% 63
2021
Q3 		$25K Buy
+133,600
New +$5.92M ﹤0.01% 605
2021
Q2 		– Sell
-20,000
Closed -$6K – 836
2021
Q1 		$6K Buy
+20,000
New +$710K ﹤0.01% 720
2020
Q2 		– Sell
-26,350
Closed -$88K – 446
2020
Q1 		$88K Buy
+26,350
New +$898K 0.01% 300
2019
Q4 		– Sell
-72,515
Closed -$27K – 702
2019
Q3 		$27K Buy
72,515
+39,946
+123% +$1.45M ﹤0.01% 413
2019
Q2 		$20K Sell
32,569
-4,848
-13% -$193K ﹤0.01% 289
2019
Q1 		$33K Buy
+37,417
New +$1.5M ﹤0.01% 306
2018
Q4 		– Sell
-34,993
Closed -$22K – 511
2018
Q3 		$22K Buy
+34,993
New +$1.35M ﹤0.01% 442
2017
Q2 		– Sell
-10,540
Closed -$9K – 579
2017
Q1 		$9K Buy
+10,540
New +$332K ﹤0.01% 415
2016
Q3 		– Sell
-39,209
Closed -$100K – 549
2016
Q2 		$100K Buy
+39,209
New +$1.25M 0.01% 331
2016
Q1 		– Sell
-316,200
Closed -$108K – 672
2015
Q4 		$108K Buy
+316,200
New +$9.95M 0.01% 452
2015
Q2 		– Sell
-210,800
Closed -$383K – 508
2015
Q1 		$383K Buy
+210,800
New +$6.7M 0.04% 299
2014
Q4 		– Sell
-52,700
Closed -$2K – 853
2014
Q3 		$2K Buy
+52,700
New +$1.48M ﹤0.01% 915

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bluefin Capital Management's PFE Position: Q1 2026 in Review

Bluefin Capital Management reduced its Pfizer (PFE) stake by 45% in Q1 2026, selling an estimated $873K and leaving 39,754 shares worth $1.12M. The position accounts for 0.72% of the portfolio, ranked #28.

Bluefin Capital Management first reported a position in PFE in Q2 2013 and has held it in 40 quarters since. The position peaked at $34.4M in Q2 2013. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bluefin Capital Management held 39,754 shares of Pfizer worth $1.12M as of Q1 2026.
  • Bluefin Capital Management sold 32,788 Pfizer shares in Q1 2026, an estimated $873K.
  • Pfizer made up 0.72% of Bluefin Capital Management's portfolio in Q1 2026, its #28 holding.
  • Bluefin Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 40 quarters since.
  • Bluefin Capital Management's Pfizer position peaked at $34.4M in Q2 2013.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.